Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab + DMARDs in Early Rheumatoid Arthritis
NCT00908089Phase 4Unknown
- Sponsor
- University of Helsinki
- Start
- Mar 2003
- Primary completion
- May 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in rheumatoid arthritis (RA), sponsored by University of Helsinki. Status: unknown.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00908089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908089.